About the Authors
- Ying Chen
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Jeremy McGee
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Xianming Chen
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Thompson N. Doman
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Xueqian Gong
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Youyan Zhang
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Nicole Hamm
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Xiwen Ma
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Richard E. Higgs
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Shripad V. Bhagwat
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Sean Buchanan
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Sheng-Bin Peng
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Kirk A. Staschke
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Vipin Yadav
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Yong Yue
-
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Hosein Kouros-Mehr
-
* E-mail: kouros.mehr@gmail.com
Affiliation Department of Oncology, Eli Lilly and Company, Indianapolis, Indiana, United States of America
Competing Interests
This study was funded fully by Eli Lilly and Company, the employer of all authors. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: HKM YY. Performed the experiments: JM XC NH YZ. Analyzed the data: YC TND XG REH KAS. Contributed reagents/materials/analysis tools: XM SB SVB SBP VY. Wrote the paper: HKM.